ClinicalTrials.Veeva

Menu

Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.

M

Minia University

Status

Enrolling

Conditions

Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis

Treatments

Procedure: Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis

Enrollment

200 estimated patients

Sex

All

Ages

9 to 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Permanent Molar with closed Apex and diagnosed with irreversible pulpitis

Exclusion Criteria:

  • medically compromised children.

    • non restorable tooth
    • Necrotic tooth

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis
Experimental group
Treatment:
Procedure: Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

Trial contacts and locations

1

Loading...

Central trial contact

Mahmoud Mostafa Abdelhakim, Master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems